Spirometry and under-diagnosis of COPD in a lung cancer screening cohort
C. Bradley (Leeds, United Kingdom), M. Kennedy (Leeds, United Kingdom), A. Boland (Leeds, United Kingdom), D. Ellames (Leeds, United Kingdom), D. Dimov (Leeds, United Kingdom), R. Gabe (London, United Kingdom), P. Alexandris (London, United Kingdom), P. Crosbie (Manchester , United Kingdom), M. Callister (Leeds, United Kingdom)
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Bradley (Leeds, United Kingdom), M. Kennedy (Leeds, United Kingdom), A. Boland (Leeds, United Kingdom), D. Ellames (Leeds, United Kingdom), D. Dimov (Leeds, United Kingdom), R. Gabe (London, United Kingdom), P. Alexandris (London, United Kingdom), P. Crosbie (Manchester , United Kingdom), M. Callister (Leeds, United Kingdom). Spirometry and under-diagnosis of COPD in a lung cancer screening cohort. 4315
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: